Abstract
Malignant ascites (MA) carries a poor prognosis. It can have a significant impact on quality of life (QOL), with increasing abdominal distention, pain, and dyspnea. Diuretics typically do not work well for MA. Paracentesis is effective in providing temporary symptom relief but requires frequent repeat procedures. Options for durable symptom management include indwelling catheters, peritoneal ports, peritoneovenous shunts, intraperitoneal (i.p.) catumaxomab, and hyperthermic i.p. chemotherapy. These interventions do not necessarily improve overall survival but may improve QOL.
| Original language | English (US) |
|---|---|
| Pages (from-to) | 67-73 |
| Number of pages | 7 |
| Journal | Journal of surgical oncology |
| Volume | 120 |
| Issue number | 1 |
| DOIs | |
| State | Published - Jul 1 2019 |
Keywords
- catumaxomab
- hyperthermic intraperitoneal chemotherapy
- paracentesis
- peritoneal carcinomatosis
ASJC Scopus subject areas
- Surgery
- Oncology